Psychemedics Corporation (PMDI)

Market Cap	14.05M
Revenue (ttm)	19.69M
Net Income (ttm)	-1.86M
Shares Out	6.11M
EPS (ttm)	-0.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,600
Average Volume	4,491
Open	2.180
Previous Close	2.300
Day's Range	2.180 - 2.300
52-Week Range	1.110 - 2.770
Beta	0.48
RSI	50.71
Earnings Date	Aug 12, 2025

About Psychemedics

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; syntheti...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1986
• Employees: 101
• Stock Exchange: OTCMKTS
• Ticker Symbol: PMDI

Financial Performance

In 2024, Psychemedics's revenue was $19.69 million, a decrease of -10.92% compared to the previous year's $22.10 million. Losses were -$1.86 million, -55.20% less than in 2023.